4.6 Article

Guanidinylated neomycin delivers large, bioactive cargo into cells through a heparan sulfate-dependent pathway

Journal

JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 282, Issue 18, Pages 13585-13591

Publisher

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M700463200

Keywords

-

Funding

  1. NCI NIH HHS [CA67754, CA11227] Funding Source: Medline
  2. NIAID NIH HHS [AI47673, 5F31AI05891602] Funding Source: Medline
  3. NIGMS NIH HHS [GM77471, GM33063] Funding Source: Medline
  4. NINDS NIH HHS [NS047101] Funding Source: Medline

Ask authors/readers for more resources

Facilitating the uptake of molecules into living cells is of substantial interest for basic research and drug delivery applications. Arginine-rich peptides have been shown to facilitate uptake of high molecular mass cargos into cells, but the mechanism of uptake is complex and may involve multiple receptors. In this report, we show that a derivative of the aminoglycoside antibiotic neomycin, in which all of the ammonium groups have been converted into guanidinium groups, can carry large (> 300 kDa) bioactive molecules across cell membranes. Delivery occurs at nanomolar transporter concentrations and under these conditions depends entirely on cell surface heparan sulfate proteoglycans. Conjugation of guanidinoneomycin to the plant toxin saporin, a ribosome-inactivating agent, results in proteoglycan-dependent cell toxicity. In contrast, an arginine-rich peptide shows both heparan sulfate-dependent and -independent cellular uptake. The high selectivity of guanidi-noneomycin for heparan sulfate suggests the possibility of exploiting differences in proteoglycan compositions to target delivery to different cell types.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available